genia tagger: 91('ldl', 16)
('72\xe2\x80\x93118', 2)
('cardiovascular', 43)
('83\xe2\x80\x93146', 2)
('\\?', 77)
('segments', 10)
('condition\\.', 1)
('fib', 52)
('340', 11)
('mg\\/dl', 65)
('samples', 4)
('56\\.9\\\xc2\\\xb19\\.8', 2)
('\\(', 293)
('\\)', 293)
('risk', 49)
('128', 2)
('crp', 64)
('hdl-c', 2)
('129\xc2\xb161', 2)
('pro-inflammatory', 8)
('trend', 2)
('f\\=13\\.6', 2)
('nontraditional', 1)
('80', 8)
('119', 2)
('87', 6)
('84', 4)
('established', 10)
('55\\.8\\\xc2\\\xb111\\.1', 2)
('factors', 21)
('markers', 17)
('118\xc2\xb145', 2)
('3', 316)
('\xc2\xa0\xc2\xa0crp', 6)
('caucasian', 70)
('79\xe2\x80\x93142', 2)
('3\\.0', 17)
('106', 2)
('105', 6)
('112\xe2\x80\x93206', 2)
('r2', 4)
('insulin', 122)
('\\<', 80)
('inflammatory', 24)
('table', 16)
('apob-containing', 2)
('fibrinogen', 48)
('2', 354)
('115\xe2\x80\x93222', 2)
('yrs', 12)
('\xc2\xa0\xc2\xa0glucose', 6)
('populations', 4)
('bmi', 12)
('56\\.4\\\xc2\\\xb19\\.9', 2)
('56\\.6\\\xc2\\\xb110\\.3', 2)
('cad\\.', 4)
('0\\.001', 54)
('85\xe2\x80\x93134', 2)
('162', 2)
('15', 32)
('caucasians', 60)
('n\\=344', 2)
('mo', 73)
('n', 2522)
('\xc2\xb1', 170)
('cvd', 14)
('cad', 42)
('\xc2\xa0\xc2\xa0triglyceride', 6)
('0\\.015', 2)
('154', 2)
('classic', 1)
('ir', 96)
('100\xe2\x80\x93192', 2)
('rib', 23)
('lipoproteins', 2)
('115\xe2\x80\x93205', 2)
('1', 564)
('\\\xc2\\\xb5u\\/ml', 6)
('ns', 401)
('202', 2)
('143', 2)
('\xc2\xa0\xc2\xa0insulin', 6)
('74', 4)
('blood', 10)
('79', 4)
('\xc2\xa0\xc2\xa0bmi', 6)
('homa-ir', 67)
('vs\\.', 24)
('disease', 10)
('\xc2\xa0\xc2\xa0age', 6)
('sd', 6)


spacy + metamap: 364('partial', 4)
('lack', 2)
('systemic', 1)
("t\\'", 2)
('97', 2)
('risk factors', 19)
('risk', 49)
('activation', 3)
('cross-sectional study', 2)
('fibrinogen levels', 9)
('artery', 7)
('difference', 10)
('stimulus', 2)
('gender', 12)
('mercury sphygmomanometer', 2)
('cholesterol', 36)
('obesity', 3)
('findings', 4)
('trend', 2)
('prediction', 8)
('zero', 2)
('further', 16)
('established', 10)
('coronary arteriography', 2)
('international', 2)
('method', 3)
('contrast', 2)
('degree', 16)
('nhanes', 3)
('men', 51)
('groups', 26)
('active', 2)
('standard', 8)
('healthy', 5)
('study', 27)
('insulin', 122)
('inflammatory condition', 1)
('history', 2)
('waist circumference', 2)
('distributed', 4)
('exercise', 2)
('marker', 17)
('total', 12)
('use', 4)
('positive', 10)
('hospital', 8)
('two', 5)
('france', 2)
('duplicate', 2)
('type', 5)
('more', 6)
('0\\%', 8)
('menopausal status', 2)
('populations', 4)
('supplemental', 4)
('women', 4)
('mg', 93)
('ml', 6)
('mo', 73)
('values', 8)
('cad', 42)
('diabetic', 6)
('process', 2)
('sps', 4)
('high', 44)
('serum', 2)
('lipoproteins', 2)
('blood pressure', 8)
('one-way anova', 2)
('discussion', 2)
('mg\\/l', 28)
('group mean', 6)
('different', 1)
('cardiovascular disease', 6)
('data', 8)
('waist', 8)
('triglyceride', 32)
('software', 2)
('sd', 6)
('gradual', 4)
('\\<50', 2)
('coronary', 26)
('cardiovascular', 43)
('group', 36)
('23', 22)
('presence', 13)
('surgeons', 2)
('fib', 52)
('composite score', 16)
('fig', 18)
('main', 6)
('physicians', 2)
('non', 13)
('combination', 10)
('atherosclerosis', 1)
('diabetes status', 2)
('effects', 2)
('association', 16)
('mmhg', 6)
('university', 4)
('l-', 2)
('coagulation', 1)
('incomplete data', 2)
('metabolic syndrome', 2)
('mean', 14)
('hormone replacement', 2)
('coronary angiography', 7)
('dyslipidemia', 1)
('plasma sample', 2)
('related', 5)
('third national health and nutrition examination survey', 1)
('frequency', 4)
('measure', 20)
('laboratory', 4)
('alcohol', 12)
('increase', 14)
('participants', 2)
('reader', 4)
('issue', 1)
('caucasian', 70)
('world health organization', 2)
('low fibrinogen', 3)
('mechanisms', 2)
('diagnostic', 5)
('base', 8)
('california', 2)
('prevention study', 2)
('log', 13)
('r2', 4)
('hdl cholesterol', 14)
('honest', 2)
('introduction', 1)
('first', 2)
('prospective', 4)
('major', 7)
('cardiovascular risk factor', 8)
('variables', 10)
('number', 2)
('3 4', 6)
('normal distributions', 2)
('unknown', 2)
('fibrinogen', 48)
('roche', 2)
('1b', 2)
('recent', 5)
('african americans', 56)
('glucose', 13)
('hypertriglyceridemia', 2)
('synergistic', 6)
('population', 18)
('niddm', 6)
('roles', 1)
('rate', 17)
('significantly high', 10)
('patients', 14)
('biochemical', 4)
('lowest', 4)
('clinical studies', 2)
('endocrinology', 2)
('pro', 37)
('diagnostic coronary angiography', 1)
('dextran sulfate', 2)
('apparently', 1)
('ethnic groups', 15)
('quartile', 30)
('scotland', 2)
('majority', 2)
('potential', 5)
('finding', 6)
('interquartile range', 4)
('stenosis', 12)
('multiple', 9)
('supplementary material', 2)
('centre', 2)
('luminal', 2)
('significant', 24)
('measured', 14)
('clinical diagnosis', 2)
('average', 2)
('sigma', 2)
('random', 2)
('asia', 72)
('\\/dl', 65)
('parameters', 4)
('proportion', 3)
('enzyme', 2)
('factor', 32)
('\\/ml', 6)
('frequency distribution', 2)
('\\<3', 9)
('new york city', 2)
('overall', 7)
('report', 6)
('african american', 68)
('procedures', 2)
('secondary', 2)
('crp', 64)
('morning', 2)
('signaling pathways', 1)
('common', 3)
('view', 3)
('reference', 2)
('college', 2)
('result', 21)
('subject', 49)
('phases', 1)
('apob', 2)
('pattern', 2)
('insulin levels', 2)
('state', 2)
('score', 44)
('60\\%', 2)
('europe', 2)
('high risk', 6)
('extent', 5)
('contribution', 4)
('adjusted', 4)
('inflammatory', 24)
('subclinical', 1)
('reasons', 2)
('table', 16)
('s t', 27)
('complication', 1)
('west', 6)
('initiation', 1)
('combined', 2)
('location', 2)
('adipokine', 1)
('determination', 2)
('smoking', 14)
('assessments', 4)
('present', 4)
('novel', 2)
('caucasians', 60)
('ongoing', 2)
('expiration', 2)
('hdl', 16)
('31', 16)
('prevalence', 5)
('characteristics', 12)
('ir', 96)
('homeostasis model assessment', 2)
('statistical analysis', 2)
('rib', 23)
('ethnicity', 21)
('containing', 2)
('il', 49)
('elevated', 6)
('risk factor', 30)
('several', 1)
('events', 1)
('higher', 20)
('development', 4)
('independent', 23)
('practice', 2)
('columbia', 2)
('study design', 2)
('effect', 5)
('levels', 54)
('purpose', 1)
('identity', 2)
('diabetes', 13)
('lower', 6)
('center', 2)
('studies', 19)
('analysis', 12)
('materials', 1)
('middle-aged men', 2)
('model', 7)
('coronary artery disease', 3)
('prevention', 2)
('clot', 2)
('50\\%', 4)
('study population', 6)
('previous', 4)
('tables', 2)
('transformed', 10)
('treatment', 2)
('plasma', 3)
('associations', 2)
('increased', 4)
('possible', 1)
('general population', 2)
('precipitation', 2)
('acute', 4)
('55', 8)
('drink alcohol', 6)
('either', 8)
('conclusion', 3)
('replacement', 2)
('methods', 1)
('people', 1)
('atherosclerotic plaque', 1)
('growth', 1)
('lipid lowering drug', 2)
('scale', 2)
('measurements', 2)
('ethnic group', 17)
('pathogenesis', 6)
('inflammation', 49)
('regression analyses', 4)
('limitations', 2)
('patient', 20)
('agreement', 2)
('multiple regression', 7)
('comparison', 2)
('coronary artery', 7)
('months', 2)
('insulin resistance', 98)
('concentrations', 2)
('predictor', 7)
('ldl cholesterol', 16)
('inclusion', 2)
('blood samples', 2)
('iliac crest', 2)
('\\/d', 65)
('metabolic condition', 1)
('\\/l', 28)
('coronary symptoms', 2)
('additional', 2)
('segment', 10)
('support', 2)
('metabolic', 7)
('normality', 2)
('clinical', 18)
('low', 20)
('catheterization procedure', 2)
('surgical intervention', 2)
('highest', 4)
('exclusion criteria', 4)
('clinical characteristics', 8)
('assessment', 7)
('fatty streak', 1)
('oxidative stress', 1)
('distribution', 8)
('similar', 7)
('informed consent', 2)
('classic', 1)
('regression analysis', 2)
('hypertension', 11)
('statistical significance', 2)
('triglycerides', 2)
('nj', 2)
('prospective studies', 2)
('triglyceride level', 4)
('ny', 8)
('narrowing', 2)
('role', 13)
('test', 8)
('ns', 401)
('hdl cholesterol levels', 2)
('separate', 5)
('alcohol consumption', 4)
('update', 2)
('important', 2)
('pathways', 3)
('variable', 12)
('fisher', 2)
('inspiration', 2)
('exact test', 2)
('age', 22)
('curve', 2)
('depth', 2)
('12 hours', 2)


total: 433('partial', 4)
('lack', 2)
('systemic', 1)
('markers', 17)
("t\\'", 2)
('segments', 10)
('340', 11)
('162', 2)
('56\\.9\\\xc2\\\xb19\\.8', 2)
('risk factors', 19)
('risk', 49)
('activation', 3)
('cross-sectional study', 2)
('fibrinogen levels', 9)
('artery', 7)
('difference', 10)
('stimulus', 2)
('gender', 12)
('mercury sphygmomanometer', 2)
('cholesterol', 36)
('obesity', 3)
('findings', 4)
('trend', 2)
('prediction', 8)
('zero', 2)
('dextran sulfate', 2)
('established', 10)
('coronary arteriography', 2)
('international', 2)
('method', 3)
('contrast', 2)
('79\xe2\x80\x93142', 2)
('degree', 16)
('nhanes', 3)
('men', 51)
('agreement', 2)
('groups', 26)
('3\\.0', 17)
('active', 2)
('standard', 8)
('106', 2)
('105', 6)
('healthy', 5)
('study', 27)
('insulin', 122)
('inflammatory condition', 1)
('history', 2)
('waist circumference', 2)
('distributed', 4)
('exercise', 2)
('marker', 17)
('total', 12)
('use', 4)
('positive', 10)
('hospital', 8)
('two', 5)
('france', 2)
('duplicate', 2)
('assessment', 7)
('more', 6)
('0\\%', 8)
('menopausal status', 2)
('populations', 4)
('85\xe2\x80\x93134', 2)
('supplemental', 4)
('women', 4)
('mg', 93)
('n\\=344', 2)
('ml', 6)
('mo', 73)
('values', 8)
('cad', 42)
('0\\.015', 2)
('diabetic', 6)
('process', 2)
('sps', 4)
('high', 44)
('serum', 2)
('lipoproteins', 2)
('blood pressure', 8)
('one-way anova', 2)
('discussion', 2)
('1', 564)
('mg\\/l', 28)
('group mean', 6)
('143', 2)
('\xc2\xa0\xc2\xa0insulin', 6)
('different', 1)
('cardiovascular disease', 6)
('data', 8)
('homa-ir', 67)
('waist', 8)
('triglyceride', 32)
('software', 2)
('sd', 6)
('gradual', 4)
('128', 2)
('\\<50', 2)
('72\xe2\x80\x93118', 2)
('coronary', 26)
('cardiovascular', 43)
('group', 36)
('23', 22)
('presence', 13)
('surgeons', 2)
('fib', 52)
('composite score', 16)
('fig', 18)
('main', 6)
('physicians', 2)
('non', 13)
('combination', 10)
('atherosclerosis', 1)
('diabetes status', 2)
('effects', 2)
('1b', 2)
('association', 16)
('mmhg', 6)
('university', 4)
('l-', 2)
('coagulation', 1)
('incomplete data', 2)
('metabolic syndrome', 2)
('mean', 14)
('hormone replacement', 2)
('coronary angiography', 7)
('dyslipidemia', 1)
('plasma sample', 2)
('related', 5)
('third national health and nutrition examination survey', 1)
('frequency', 4)
('measure', 20)
('laboratory', 4)
('80', 8)
('87', 6)
('84', 4)
('alcohol', 12)
('55\\.8\\\xc2\\\xb111\\.1', 2)
('factors', 21)
('increase', 14)
('participants', 2)
('reader', 4)
('issue', 1)
('caucasian', 70)
('world health organization', 2)
('low fibrinogen', 3)
('mechanisms', 2)
('diagnostic', 5)
('base', 8)
('california', 2)
('prevention study', 2)
('additional', 2)
('r2', 4)
('hdl cholesterol', 14)
('honest', 2)
('introduction', 1)
('first', 2)
('prospective', 4)
('major', 7)
('cardiovascular risk factor', 8)
('variables', 10)
('number', 2)
('3 4', 6)
('normal distributions', 2)
('unknown', 2)
('fibrinogen', 48)
('roche', 2)
('2', 354)
('115\xe2\x80\x93222', 2)
('recent', 5)
('african americans', 56)
('glucose', 13)
('\xc2\xa0\xc2\xa0glucose', 6)
('hypertriglyceridemia', 2)
('cad\\.', 4)
('synergistic', 6)
('population', 18)
('niddm', 6)
('15', 32)
('roles', 1)
('rate', 17)
('significantly high', 10)
('patients', 14)
('biochemical', 4)
('lowest', 4)
('clinical studies', 2)
('endocrinology', 2)
('pro', 37)
('100\xe2\x80\x93192', 2)
('diagnostic coronary angiography', 1)
('further', 16)
('apparently', 1)
('ethnic groups', 15)
('quartile', 30)
('scotland', 2)
('majority', 2)
('potential', 5)
('finding', 6)
('\\\xc2\\\xb5u\\/ml', 6)
('stenosis', 12)
('202', 2)
('multiple', 9)
('supplementary material', 2)
('centre', 2)
('74', 4)
('significant', 24)
('measured', 14)
('clinical diagnosis', 2)
('average', 2)
('disease', 10)
('prevention', 2)
('sigma', 2)
('random', 2)
('asia', 72)
('\\/dl', 65)
('83\xe2\x80\x93146', 2)
('parameters', 4)
('proportion', 3)
('state', 2)
('enzyme', 2)
('mg\\/dl', 65)
('factor', 32)
('\\/ml', 6)
('frequency distribution', 2)
('\\<3', 9)
('new york city', 2)
('overall', 7)
('report', 6)
('african american', 68)
('procedures', 2)
('secondary', 2)
('crp', 64)
('129\xc2\xb161', 2)
('morning', 2)
('signaling pathways', 1)
('common', 3)
('pro-inflammatory', 8)
('view', 3)
('reference', 2)
('college', 2)
('result', 21)
('nontraditional', 1)
('subject', 49)
('phases', 1)
('apob', 2)
('pattern', 2)
('insulin levels', 2)
('3', 316)
('score', 44)
('60\\%', 2)
('europe', 2)
('high risk', 6)
('extent', 5)
('contribution', 4)
('adjusted', 4)
('inflammatory', 24)
('subclinical', 1)
('reasons', 2)
('97', 2)
('\xc2\xa0\xc2\xa0bmi', 6)
('table', 16)
('s t', 27)
('complication', 1)
('west', 6)
('initiation', 1)
('combined', 2)
('treatment', 2)
('adipokine', 1)
('bmi', 12)
('56\\.4\\\xc2\\\xb19\\.9', 2)
('56\\.6\\\xc2\\\xb110\\.3', 2)
('determination', 2)
('smoking', 14)
('assessments', 4)
('present', 4)
('novel', 2)
('caucasians', 60)
('n', 2522)
('ongoing', 2)
('expiration', 2)
('cvd', 14)
('hdl', 16)
('31', 16)
('prevalence', 5)
('characteristics', 12)
('blood', 10)
('ir', 96)
('homeostasis model assessment', 2)
('statistical analysis', 2)
('rib', 23)
('ethnicity', 21)
('containing', 2)
('il', 49)
('elevated', 6)
('risk factor', 30)
('several', 1)
('events', 1)
('higher', 20)
('development', 4)
('independent', 23)
('practice', 2)
('columbia', 2)
('study design', 2)
('effect', 5)
('levels', 54)
('purpose', 1)
('identity', 2)
('diabetes', 13)
('lower', 6)
('center', 2)
('vs\\.', 24)
('studies', 19)
('analysis', 12)
('materials', 1)
('middle-aged men', 2)
('model', 7)
('coronary artery disease', 3)
('\xc2\xa0\xc2\xa0age', 6)
('ldl', 16)
('clot', 2)
('50\\%', 4)
('study population', 6)
('previous', 4)
('tables', 2)
('\\?', 77)
('\\<', 80)
('condition\\.', 1)
('transformed', 10)
('location', 2)
('samples', 4)
('plasma', 3)
('\\(', 293)
('\\)', 293)
('associations', 2)
('increased', 4)
('possible', 1)
('general population', 2)
('interquartile range', 4)
('precipitation', 2)
('acute', 4)
('55', 8)
('hdl-c', 2)
('drink alcohol', 6)
('either', 8)
('conclusion', 3)
('replacement', 2)
('methods', 1)
('people', 1)
('f\\=13\\.6', 2)
('metabolic', 7)
('atherosclerotic plaque', 1)
('growth', 1)
('119', 2)
('lipid lowering drug', 2)
('scale', 2)
('measurements', 2)
('ethnic group', 17)
('pathogenesis', 6)
('118\xc2\xb145', 2)
('inflammation', 49)
('\xc2\xa0\xc2\xa0crp', 6)
('regression analyses', 4)
('limitations', 2)
('patient', 20)
('apob-containing', 2)
('multiple regression', 7)
('comparison', 2)
('112\xe2\x80\x93206', 2)
('coronary artery', 7)
('months', 2)
('insulin resistance', 98)
('concentrations', 2)
('predictor', 7)
('ldl cholesterol', 16)
('inclusion', 2)
('blood samples', 2)
('iliac crest', 2)
('\\/d', 65)
('metabolic condition', 1)
('\\/l', 28)
('coronary symptoms', 2)
('log', 13)
('segment', 10)
('support', 2)
('luminal', 2)
('normality', 2)
('clinical', 18)
('low', 20)
('yrs', 12)
('catheterization procedure', 2)
('surgical intervention', 2)
('0\\.001', 54)
('highest', 4)
('exclusion criteria', 4)
('clinical characteristics', 8)
('type', 5)
('fatty streak', 1)
('oxidative stress', 1)
('\xc2\xb1', 170)
('distribution', 8)
('similar', 7)
('informed consent', 2)
('\xc2\xa0\xc2\xa0triglyceride', 6)
('154', 2)
('classic', 1)
('regression analysis', 2)
('hypertension', 11)
('statistical significance', 2)
('triglycerides', 2)
('nj', 2)
('prospective studies', 2)
('79', 4)
('triglyceride level', 4)
('115\xe2\x80\x93205', 2)
('ny', 8)
('narrowing', 2)
('role', 13)
('test', 8)
('ns', 401)
('hdl cholesterol levels', 2)
('separate', 5)
('alcohol consumption', 4)
('update', 2)
('important', 2)
('pathways', 3)
('variable', 12)
('fisher', 2)
('inspiration', 2)
('exact test', 2)
('age', 22)
('curve', 2)
('depth', 2)
('12 hours', 2)
